Welcome to Rhineland-Palatinate and Mainz – 
a hub for biotechnology and life sciences!

Benefits and prospects for the region:

  • > 500

    research projects with a biotech focus are currently underway across the state.

  • 13,6

    patents per million inhabitants, making Rhineland-Palatinate Germany's foremost centre of scientific innovation.

  • TOP 3

    worldwide: Mainz is ranked among the top global locations in the field of mRNA-based vaccines.

  • > 55 k

    employs the biotechnology sector in Rhineland-Palatinate – and rising.

A new promotional video by the state and the city of Mainz focuses on these and other aspects while highlighting the benefits and prospects the region offers companies, start-ups and people involved in scientific research. 

Today, the German state of Rhineland-Palatinate and its capital, Mainz, have established themselves as a leading hub for research, science and business that boasts a wealth of expertise. This is where fundamental research makes the transition into real-world applications. 

Alongside a number of leading global players and centres of scientific excellence as well as a high level of AI proficiency, there is also a thriving start-up ecosystem throughout the state that is constantly working to shape a better future with creativity and an enterprising mindset.

TALK.ABOUT.BIOTECH

In the image film, we spoke to four people about why they believe the region already offers the best conditions for students, researchers, founders and companies from all over the world.

Find out more about their tasks, their motivation and their plans and visions for the future in the comprehensive interviews:

Rhineland-Palatinate: Leader in biotechnology

Prof. Dr. Eckhard Thines, State Coordinator for Biotechnology and Dean of the Department of Biology at JGU, provides insights into the strengths of Rhineland-Palatinate as a biotech hub. Find out why our state is a world leader in red, green and white biotechnology.

Ideal ecosystem for biotech start-ups in Rhineland-Palatinate

Prof. Dr. Andrea Tüttenberg, CEO of ActiTrexx GmbH, shares her experiences as a founder. Discover how the combination of talented young scientists, start-up success stories such as BioNTech and established pharmaceutical companies makes Rhineland-Palatinate a magnet for biotech innovators.

»Rhineland-Palatinate is a great place to found a biotech start-up«

Prof. Dr. Andrea Tüttenberg, CEO and co-founder of ActiTrexx GmbH

Synergies in biotechnology: the key to success

Dr. Fridtjof Traulsen from Boehringer Ingelheim Deutschland GmbH explains the importance of strategic partnerships. Learn how cooperation between industry, research and politics is driving biotechnology in Rhineland-Palatinate and promoting innovation.

Mainz: Building bridges between science and industry

Iris Lade, PhD student in the ATLAS program, reports on the unique opportunities for aspiring researchers in Mainz. Discover how the close integration of university and industry creates optimal conditions for the development of future biotech experts.